Clinical trial (third line treatment) lurbinectedin and irinotecan
Starting a clinical trial this week for stage iv pancreatic cancer. Trial doesn’t target a specific mutation but it does target neuroendocrine tumors. Was on Gem/Abrax for few months and cancer started to show resistance. Options were explore trials or stay on chemo and eventually comfort care and hospice. Been off of chemo for 2 weeks for a flush to start the trial drug and cancer has progressed- symptoms have worsened. Will be starting a trial with the drugs lurbinectedin and irinotecan. The lurbinectedin is the trial drug. Just wanted to get anyones thoughts on trials and if they’re familiar with the trial drug. It is approved for Small Cell Lung Cancer but is now being tested with gastro cancers.